Mallikarjuna Sunkara

  • Citations Per Year
Learn More
BACKGROUND AIMS Cell replacement therapy is considered a promising alternative in the treatment of degenerative diseases, and in this context, mesenchymal stromal cells (MSCs) have been proposed for transplantation in Parkinson disease (PD). Thus far, the results of animal studies are found to be inconsistent and inconclusive regarding the therapeutic(More)
  • 1